Zur Kurzanzeige

Einfluss des Lipoxygenaseinhibitors Baicalein in unterschiedlicher Dosierung auf den Skelettmuskel der ovariektomierten Ratte

dc.contributor.advisorSehmisch, Stephan PD Dr.
dc.contributor.authorKling, Jens Henning
dc.date.accessioned2016-11-02T08:17:28Z
dc.date.available2016-12-01T23:50:05Z
dc.date.issued2016-11-02
dc.identifier.urihttp://hdl.handle.net/11858/00-1735-0000-002B-7C5D-4
dc.identifier.urihttp://dx.doi.org/10.53846/goediss-5928
dc.language.isodeude
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject.ddc610de
dc.titleEinfluss des Lipoxygenaseinhibitors Baicalein in unterschiedlicher Dosierung auf den Skelettmuskel der ovariektomierten Rattede
dc.typedoctoralThesisde
dc.title.translatedEffect of the lipoxygenase inhibitor baicalein on muscles in ovariectomized ratsde
dc.contributor.refereeSehmisch, Stephan PD Dr.
dc.date.examination2016-11-24
dc.description.abstractengSummary In estrogen-deficient rats, baicalein was found to rectify the muscle atrophy measured in fibre diameter and fibre area. The number of capillaries per fibre was raised and serum creatine kinase levels were also significantly reduced. Purpose During osteoporosis, which is one of the world’s most common illnesses, sarcopenia leads to falls and fall-related injuries. Especially in older women, estrogen-induced loss of muscle mass, through generally unknown mechanisms, accompanies osteoporosis. Baicalein, as a phytochemical agent, has an antioxidative effect and suppresses various inflammatory processes in muscle and bone. Methods Sixty-one female Sprague Dawley rats were divided into five groups: four groups were ovariectomized (OVX) and one control group was non-ovariectomized (NON-OVX). Eight weeks after ovariectomy, three disparate concentrations (1 mg/kg body weight [bw], 10 mg/kg bw, and 100 mg/kg bw) of baicalein were applied subcutaneously daily in three OVX groups. M. soleus, M. gastrocnemius and M. longissimus were extracted; their diameter, area and relation to body and muscle weights were calculated. Serum levels of calcium, magnesium, and creatine kinase were measured, and the number of capillaries per muscle fibre was recorded microscopically. Results In M. soleus and M. gastrocnemius, the baicalein effect on capillaries—of increasing number of capillaries per fibre — was proportional to the dose applied, whereas in M. longissimus, the moderate concentration had the supreme effect. The fibre diameters under baicalein treatment were significantly greater when compared with the non-treated OVX and NON-OVX groups; equivalent results could be discerned in the fibre area, with the greatest effect seen in the moderate baicalein concentration group. In M. longissimus, we observed a shift to type IIa fibres. The serum creatine kinase levels were significantly lower in the highest baicalein concentration group. Conclusions Baicalein can stimulate angiogenesis, though not fibre-type specific, in skeletal muscle and reduce the estrogen-related loss of fibre diameter and fibre area in the skeletal muscle in rats. Therefore, a protective effect of baicalein on muscle cells can be assumed.de
dc.contributor.coRefereeSchmidt, Jens PD Dr.
dc.subject.gerBaicaleinde
dc.subject.gerOsteoporosede
dc.subject.gerSarkopeniede
dc.subject.gerMuskelfaserde
dc.subject.gerRattede
dc.subject.engBaicaleinde
dc.subject.engOsteoporosisde
dc.subject.engSarcopeniade
dc.subject.engRatde
dc.subject.engMuscle fibrede
dc.identifier.urnurn:nbn:de:gbv:7-11858/00-1735-0000-002B-7C5D-4-5
dc.affiliation.instituteMedizinische Fakultätde
dc.subject.gokfullOrthopädie (PPN619876204)de
dc.description.embargoed2016-12-01
dc.identifier.ppn871654180


Dateien

Thumbnail

Das Dokument erscheint in:

Zur Kurzanzeige